Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
Status:
Unknown status
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to monitor the safety of continued DN-101 and docetaxel
treatment for subjects previously enrolled in DN101-002 (ASCENT) or DN101-004 (NSCLC)
Studies.